cha2ds2vasc score wikipedia cha2ds2vasc score from wikipedia free encyclopedia this old revis page edit footlessmous talk contrib 0023 14 octob 2020 categorycs1 error deprec paramet via wpjwb the present address url perman link revis may differ signific current revis revis 0023 14 octob 2020 footlessmous talk contrib categorycs1 error deprec paramet via wpjwb diff previous revis latest revis diff newer revis diff jump navig jump search for use see chad disambigu cha2ds2vasc score purpos risk stroke nonrheumat atrial fibril the chads2 score updat version cha2ds2vasc score clinic predict rule estim risk stroke patient nonrheumat atrial fibril af common serious heart arrhythmia associ thromboembol stroke such score use determin whether treatment requir anticoagul therapi antiplatelet therapy1 sinc af caus stasi blood upper heart chamber lead format mural thrombus dislodg blood flow reach brain cut suppli brain caus stroke a high score correspond greater risk stroke low score correspond lower risk stroke the chads2 score simpl valid mani studies2 in clinic use chads2 score pronounc chad two supersed cha2ds2vasc score chad vasc3 give better stratif lowrisk patient content 1 chads2 2 cha2ds2vasc 3 treatment recommend 31 anticoagul 32 bleed risk 4 refer 5 extern link chads2 the chads2 score includ common stroke risk factor various proscon care discussed4 ad togeth point correspond condit present result chads2 score use estim stroke risk chads25 condit point c congest heart failur 1 h hypertens blood pressur consist 14090 mmhg treat hypertens medic 1 a age 75 year 1 d diabet mellitus 1 s2 prior stroke tia thromboembol 2 annual stroke risk 2 chads2 score risk 95 ci 0 19 1230 1 28 2038 2 40 3151 3 59 4673 4 85 63111 5 125 82175 6 182 105274 cha2ds2vasc to complement chads2 score inclus addit stroke risk modifi risk factor cha2ds2vascscor proposed6 in clinic use chads2 score supersed cha2ds2vasc score give better stratif lowrisk patient the chads2 score outperform cha2ds2vasc multipl patient group includ patient af receiv outpati elect electr cardioversion7 cha2ds2vasc condit point c congest heart failur left ventricular systol dysfunct 1 h hypertens blood pressur consist 14090 mmhg treat hypertens medic 1 a2 age 75 year 2 d diabet mellitus 1 s2 prior stroke tia thromboembol 2 v vascular diseas eg peripher arteri diseas myocardi infarct aortic plaqu 1 a age 6574 year 1 sc sex categori ie femal sex 1 thus cha2ds2vasc score refin chads268 score extend latter includ addit common stroke risk factor age 6574 femal gender vascular disease9 in cha2ds2vasc score age 75 also extra weight 2 point the maximum chads2 score 6 whilst maximum cha2ds2vasc score 9 10 might expect simpli ad column maximum score age 2 point annual stroke risk cha2ds2vasc score friberg 201210 lip 20106 95 ci6 0 02 00 0000 1 06 06 0034 2 22 16 0347 3 32 39 1776 4 48 19 0549 5 72 32 0790 6 97 36 04123 7 112 80 10260 8 108 111 03483 9 122 100 25100 major guidelin use fix annual stroke risk guidelin start anticoagul treatment ischem stroke risk 1 2 indic start anticoagul therapi howev actual risk get stroke vari accord sampl method geograph region well use appropri studi analysi methodology11 a metaanalysi various studi 2015 shown annual stroke risk less 1 13 17 studi cha2ds2vasc score 1 6 15 studi report risk 1 2 5 15 studi report risk 2 cha2ds2vasc score 212 nevertheless stroke rate vari studi set hospit vs communiti popul trial vs general ethnic etc some studi includ metaanalysi includ femal score 1 virtu gender low risk aggreg rate other includ account followup anticoagul use thus lower rate analys exclud patient ever start anticoagul condit futur error13 the cha2ds2vasc score shown increas popular time chads2 shown decreas popularity14 could part relat introduct guidelin recommend use cha2ds2vasc score stroke risk stratification14 treatment recommend the cha2ds2vasc score use 2012 subsequ european societi cardiolog guidelin manag atrial fibrillation15161718 the 2014 american colleg cardiologyamerican heart associ task forc practic guidelin heart rhythm societi guidelin also recommend use cha2ds2vasc score19 the european societi cardiolog esc18 nation institut health care excel nice20 guidelin recommend patient cha2ds2vasc score 2 oral anticoagul therapi oac vitamin k antagonist vka eg warfarin target inr 23 one direct oral anticoagul drug doac eg dabigatran rivaroxaban edoxaban apixaban recommend if patient low risk use cha2ds2vasc score 0 male 1 femal anticoagul therapi recommend in male 1 stroke risk factor cha2ds2vasc score 1 antithrombot therapi oac may consid peopl valu prefer considered21 even singl stroke risk factor confer excess risk stroke mortal posit net clinic benefit stroke prevent oral anticoagul compar treatment aspirin22 as mention thromboembol event rate differ accord various guidelin treatment threshold methodolog approaches23 anticoagul treatment recommend base cha2ds2vasc score shown follow tabl score risk anticoagul therapi considerations1524 0 male 1 femal low no anticoagul therapi no anticoagul therapi 1 male moder oral anticoagul consid oral anticoagul well control vitamin k antagonist vka eg warfarin time therapeut rang 70 direct oral anticoagul doac eg dabigatran rivaroxaban edoxaban apixaban 2 greater high oral anticoagul recommend oral anticoagul well control vitamin k antagonist vka eg warfarin time therapeut rang 70 direct oral anticoagul doac eg dabigatran rivaroxaban edoxaban apixaban base esc guidelin atrial fibril oral anticoagul recommend prefer patient one stroke risk factor ie cha2ds2vasc score 1 male 2 females25 this consist recent decis analysi model show tip point decis anticoagul chang avail safer doac drug threshold offer stroke prevent ie oral anticoagul stroke rate approxim 1year1726 those patient recommend stroke prevent treatment via oral anticoagul choic drug ie vitamin k antagonist direct oral anticoagul doac evalu use samett2r2 score help decisionmak appropri oral anticoagulant2728 bleed risk main articl hasbl stroke risk assess alway includ assess bleed risk this done use valid bleed risk score hemorr2hag hasbl score the hasbl score recommend guidelin identifi high risk patient regular review followup address revers risk factor bleed eg uncontrol hypertens labil inr excess alcohol use concomit aspirinnsaid use24 if patient take warfarin knowledg inr control need assess labil inr criterion hasbl otherwis nonwarfarin patient criterion score zero a high hasbl score reason withhold anticoagul also compar hasbl bleed risk score consid labil inr would signific underperform predict bleed warfarin would often inappropri categoris mani patient sustain bleed low risk29 refer gage bf van walraven c pearc l et al 2004 select patient atrial fibril anticoagul stroke risk stratif patient take aspirin circul 110 16 228792 doi10116101cir00001451725564093 pmid 15477396 b gage bf waterman ad shannon w boechler m rich mw radford mj 2001 valid clinic classif scheme predict stroke result nation registri atrial fibril jama 285 22 286470 doi101001jama285222864 pmid 11401607 professor gregori lip discuss cha2ds2vasc tool predict stroke risk atrial fibril karthikeyan g eikelboom jw the chads2 score stroke risk stratif atrial fibrillationfriend foe thromb haemost 2010 jul 51041458 risk stroke af va palo alto medic center stanford univers sportsmedicin program cardiomyopathi clinic retriev 20070914 b c lip gy nieuwlaat r pister r lane da crijn hj feb 2010 refin clinic risk stratif predict stroke thromboembol atrial fibril use novel risk factorbas approach euro heart survey atrial fibril chest 137 2 26372 doi101378chest091584 pmid 19762550 yarmohammadi h varr bc puwan s lieber e william sj klostermann t jasper se whitman c klein al 2012 role chads2 score evalu thromboembol risk mortal patient atrial fibril undergo direct current cardiovers acut trial substudi am j cardiol 110 2 22226 doi101016jamjcard201203017 pmid 22503581 sandhu r k bakal j a ezekowitz j a mcalist f a 10 novemb 2011 risk stratif scheme anticoagul use outcom risktreat paradox patient newli diagnos nonvalvular atrial fibril heart 97 24 204650 doi101136heartjnl2011300901 pmid 22076011 retriev 12 februari 2017 ucsf cardiolog atrial fibril medic manag cardiologyucsfedu archiv origin 29 juli 2016 retriev 12 februari 2017 friberg leif rosenqvist mårten lip gregori yh 13 januari 2012 evalu risk stratif scheme ischaem stroke bleed 182 678 patient atrial fibril swedish atrial fibril cohort studi european heart journal 33 tabl 2 doi101093eurheartjehr488 retriev 8 octob 2020 nielsen peter b 2016 stroke thromboembol event rate atrial fibril accord differ guidelin treatment threshold a nationwid cohort studi scientif report 6 27410 bibcode2016natsr627410n doi101038srep27410 pmc 4893655 pmid 27265586 gene r quinn olivia n severdija yuchiao chang daniel e singer 31 octob 2016 wide variat report rate stroke across cohort patient atrial fibril circul 135 3 20819 doi101161circulationaha116024057 pmid 27799272 s2cid 207608289 nielsen p lip g 2017 ad rigor stroke rate investig patient with atrial fibril circul 135 3 220223 doi101161circulationaha116025944 pmid 28093493 s2cid 37525194 b lip gy habboush j altman c 2019 time trend use chads2 cha2ds2vasc score geograph specialti uptak score popular onlin clinic decis tool medic refer pdf intern journal clinic practic 73 2 e13280 doi101111ijcp13280 pmid 30281876 s2cid 52916514 b camm aj lip gy de caterina r savelieva i atar d hohnlos sh hindrick g kirchhof p oct 2012 2012 focus updat esc guidelin manag atrial fibril updat 2010 esc guidelin manag atrial fibrillationdevelop special contribut european heart rhythm associ europac 14 10 1385413 doi101093europaceeus305 pmid 22923145 camm a j kirchhof p lip g y h schotten u savelieva i ernst s van gelder i c alattar n hindrick g prendergast b heidbuchel h alfieri o angelini a atar d colonna p de caterina r de sutter j goett a gorenek b heldal m hohlos s h kolh p le heuzey jy ponikowski p rutten f h vahanian a auricchio a bax j ceconi c et al oct 2010 guidelin manag atrial fibril task forc manag atrial fibril european societi cardiolog esc eur heart j 31 19 2369429 doi101093eurheartjehq278 pmid 20802247 b kirchhof paulus benussi stefano kotecha dipak ahlsson ander atar dan casadei barbara castella manuel diener hanschristoph heidbuchel hein hendrik jeroen hindrick gerhard manoli antoni s oldgren jona popescu bogdan alexandru schotten ulrich van putt bart varda panagioti agewal stefan camm john baron esquivia gonzalo budt werner carerj scipion casselman filip coca antonio de caterina raffael deftereo spiridon dobrev dobromir ferro josé m filippato gerasimo fitzsimon donna gorenek bulent guenoun maxin hohnlos stefan h kolh philipp lip gregori y h manoli athanasio mcmurray john ponikowski piotr rosenhek raphael ruschitzka frank savelieva irina sharma sanjay suwalski piotr tamargo juan lui taylor clare j van gelder isabell c voor adriaan a windeck stephan zamorano jose lui zeppenfeld katja 7 octob 2016 2016 esc guidelin manag atrial fibril develop collabor eact european heart journal 37 38 28932962 doi101093eurheartjehw210 pmid 27567408 retriev 12 februari 2017 b hindrick gerhard potpara tatjana dagr nikolao arbelo elena bax jeroen j blomströmlundqvist carina boriani giusepp castella manuel dan gheorgheandrei dilaveri polychroni e fauchier laurent 20200829 2020 esc guidelin diagnosi manag atrial fibril develop collabor european associ cardiothorac surgeri eact european heart journal doi101093eurheartjehaa612 issn 15229645 pmid 32860505 januari ct wann ls alpert js calkin h cigarroa je cleveland jc jr conti jb ellinor pt ezekowitz md field me murray kt sacco rl stevenson wg tchou pj traci cm yanci cw dec 2014 2014 ahaacchr guidelin manag patient atrial fibril report american colleg cardiologyamerican heart associ task forc practic guidelin heart rhythm societi j am coll cardiol 64 21 e176 doi101016jjacc201403022 pmid 24685669 atrial fibril manag guidanc guidelin nice wwwniceorguk june 2014 retriev 12 februari 2017 joundi ra cipriano le sposato la saposnik g stroke outcom research work group may 2016 ischem stroke risk patient with atrial fibril cha2ds2vasc score 1 systemat review metaanalysi stroke a journal cerebr circul 47 5 13647 doi101161strokeaha115012609 pmid 27026630 s2cid 3692570 fauchier l clementi n bisson a ivan f angoulv d babuti d 2016 should atrial fibril patient with onli 1 nongenderrel cha2ds2vasc risk factor be anticoagul stroke 47 7 18316 doi101161strokeaha116013253 pmid 27231269 s2cid 3666736 nielsen p larsen tb skjøth f et al 2016 stroke thromboembol event rate atrial fibril accord differ guidelin treatment threshold a nationwid cohort studi sci rep 6 27410 bibcode2016natsr627410n doi101038srep27410 pmc 4893655 pmid 27265586 b nation clinic guidelin centr june 2014 atrial fibril the manag atrial fibril london nation institut health care excel pmid 25340239 cite journal requir journal help lip gy lane da 2015 stroke prevent atrial fibril systemat review jama 313 19 195062 doi101001jama20154369 pmid 25988464 eckman mh singer de rosand j greenberg sm jan 2011 move tip point decis anticoagul patient atrial fibril circ cardiovasc qual outcom 4 1 1421 doi101161circoutcomes110958108 pmc 3058150 pmid 21139092 apostolaki s sullivan rm olshanski b lip gy nov 2013 factor affect qualiti anticoagul control among patient atrial fibril warfarin samettr score chest 144 5 155563 doi101378chest130054 pmid 23669885 proietti marco lip gregori yh juli 2015 simpl decisionmak vitamin k antagonist nonvitamin k antagonist oral anticoagul use samett2r2 score european heart journal cardiovascular pharmacotherapi 1 3 150152 doi101093ehjcvppvv012 pmid 27533987 proietti marco senoo keitaro lane deirdr a lip gregori y h apr 2016 major bleed patient nonvalvular atrial fibril impact time therapeut rang contemporari bleed risk score sci rep 6 24376 bibcode2016natsr624376p doi101038srep24376 pmc 4828703 pmid 27067661 extern link dose inform given chads2 score onlin calcul cha2ds2vasc score retriev httpsenwikipediaorgwindexphptitl cha2ds2vascscoreoldid 983392672 categori stroke medic score system hidden categori cs1 error miss period navig menu person tool not log talk contribut creat account log namespac articl talk variant view read edit view histori more search navig main page content current event random articl about wikipedia contact us donat contribut help learn edit communiti portal recent chang upload file tool what link relat chang upload file special page perman link page inform cite page wikidata item printexport download pdf printabl version languag deutsch español françai latina polski edit link this page last edit 6 decemb 2020 1215 utc this version page revis besid normal edit reason revis may version contain factual inaccuraci vandal materi compat creativ common attributionsharealik licens privaci polici about wikipedia disclaim contact wikipedia mobil view develop statist cooki statement
